Autolus Therapeutics plc

formerly AutolusIPO

Autolus - developing CAR T cell therapies for patients with cancer and autoimmune diseases

Public · London, United Kingdom · Founded 2014 · $283.0M raised

Headquarters
London
Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$283.0M
Last Round
$100.0M Corporate RoundNov 2021
Rounds
4
Type
Public

About

Clinical-stage biopharmaceutical company developing advanced CAR T cell therapies for the treatment of cancer and autoimmune diseases.

Summary

Autolus Therapeutics plc is a Biotech company based in London, United Kingdom, founded in 2014. It has raised $283.0M in total across 4 rounds, most recently a $100.0M Corporate Round round in Nov 2021. Investors include Syncona Partners, Blackstone and Woodford Investment Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundStrategic Equity InvestmentNov 2021
$100.0M

Sign up to see all 5 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Autolus Therapeutics plc on Indexed.vc
<a href="https://indexed.vc/companies/autolus-therapeutics-plc"><img src="https://indexed.vc/api/badge/company/autolus-therapeutics-plc" alt="Autolus Therapeutics plc on Indexed.vc" width="260" height="76" /></a>